70 results about "Uterine myoma" patented technology

The invention relates to a composite developing thermosensitive gel embolizing agent as well as a preparation method and application thereof. The preparation method comprises the following steps: firstly, preparing a mixed aqueous solution of an anticancer active substance, a thermosensitive material and a developing agent into composite developing thermosensitive gel; secondly, forming a composite developing thermosensitive gel embolizing agent by the composite developing thermosensitive gel and a coagulant on the scene, wherein the thermosensitive material is hydroxyl C1-4 alkyl cellulose, Pluronic, alginate or a mixture of the substances; the anticancer active substance is arsenic trioxide, docetaxel, cisplatin, carboplatin, nedaplatin, oxaliplatin, lobaplatin, miriplatin, siRNA or a mixture of the substances; the developing agent is a water-soluble developing agent of iodixanol, ioversol or iohexol and the like. The preparation method disclosed by the invention is simple and convenient, is suitable for industrial large-scale production, is particularly suitable for preparing an embolizing agent which is biodegradable and good in biocompatibility and is used for hemorrhagic diseases, and is especially suitable for preparing the composite developing thermosensitive gel embolizing agent for treating liver cancer, kidney cancer, lung cancer, prostate cancer, uterine myoma or splenic tumor and the like.

The present invention generally relates to a medical apparatus. More particularly, the present invention relates to an apparatus for delivering a medium to body cavity of mammals including a human, especially to an apparatus for expanding rectum. Specifically, the present invention relates to the field of focused ultrasound treatment with a main purpose to provide an auxiliary device for ultrasound therapy applied to uterine myoma so as to avoid damage by ultrasound after focused within body. Therefore, the present invention provides an apparatus for blocking ultrasound, comprising (1) lead-in means for entering into said body cavity; and (2) accommodation means for containing ultrasound blocking medium, which enwraps the lead-in means outside.

The invention discloses a medicinal composition for treating hyperplastic diseases of breast and hysteromyoma and a preparation method thereof. The medicinal composition is prepared from Chinese thorowax root, nutgrass galingable rhizome, Chinese rhubarb (heated with rice wine), green tangerine peel, Szechuan lovage rhizome, zedoary root, ground beetle, thunberg fritillary bulb, Chinese angelica, white paeony root and cowherb seed, can be prepared into pills, tablets, capsules, granules, oral liquid and syrup, and has the characteristics of definite curative effect, better effect on improving clinical symptoms and fewer side effects.

The invention provides a traditional Chinese medicine composition for treating lobular hyperplasia of mammary glands and breast tumor. The traditional Chinese medicine composition consists of the following components in certain parts by weight: Chinese thorowax root, nutgrass galingale rhizome, Chinese angelica, Szechuan lovage rhizome, danshen root, pangolin scales, zedoary rhizome, milkvetch root, Indian buead, motherwort herb, common burreed rhizome, deerhorn, dried tangerine peel, green tangerine peel, peach seeds, bulb of thunberg fritillary, fruit-spike of common selfheal, frankincense, tangerine seeds, licorice root, cowherb seed, safflower, turmeric root-tuber, towel gourd vegetable sponge, cochinchnese asparagus root, Mongolian dandelion herb, pseudobulb of appendiculate cremastra, corydalis tuber, beautiful sweetgum fruit, honeysuckle flower, coptis chinensis, figwort root, pinellia tuber and glossy privet fruit. The traditional Chinese medicine composition provided by the invention can be used for treating diseases such as lobular hyperplasia of mammary glands, breast benign tumor and uterine myoma, is significant in effect, cannot cause toxic or side effects, ensures that the effective treatment rate can reach 96%, and is not easy to cause recurrence.

The invention discloses a Chinese medicinal compound preparation for treating uterine myoma. The Chinese medicinal compound preparation consists of a preparation for oral administration and a preparation for external application, wherein the preparation for oral administration comprises the following components in part by weight: 5 to 15 parts of Chinese angelica, 5 to 15 parts of szechuan lovage rhizome, 5 to 15 parts of rehmanniae vaporata, 5 to 15 parts of white paeony root, 6 to 18 parts of salivia chinensis, 6 to 18 parts of fibrous ginseng root, 5 to 15 parts of pangolin scales (concoction), 5 to 15 parts of common burreed rhizome, 10 to 20 parts of zedoary, 25 to 35 parts of calcined oyster shell, 5 to 15 parts of scrophularia root, 6 to 18 parts of root of red-rooted salvia, 6 to 18 parts of dipsacus root, 5 to 15 parts of poria, 5 to 15 parts of panax notoginseng, 5 to 15 parts of kelp, 15 to 25 parts of european verbena, 5 to 15 parts of cowherb seed, 5 to 15 parts of Indian iphigenia bulb and 5 to 15 parts of brittle falsepimpernel herb; and the preparation for external application comprises the following components in part by weight: 4 to 16 parts of nux vomica, 5 to 15 parts of pnus massoniana leaf, 5 to 17 parts of siam psychotria leaf, 4 to 15 parts of bead tree leaf, 3 to 16 parts of whiteflower leadword root leaf, 5 to 16 parts of common jasminorange leaf and twig and 4 to 17 parts of glechoma hederacea L. The Chinese medicinal compound preparation for treating the uterine myoma has the advantages of short course of treatment, definite and obvious curative effect and no side effect by applying the pharmacology and medicinal effect of the oral administration and external application of traditional Chinese medicines.

The invention relates to the technical field of medicinal preparations, in particular to a medicament for treating uterine myoma. The medicament consists of the following raw materials in part by weight: 100 to 500 parts of Chinese angelica, 50 to 400 parts of tree peony bark, 50 to 400 parts of red paeony root, 50 to 400 parts of radix bupleuri, 50 to 400 parts of peach seed, 50 to 400 parts of tangerine peel, 100 to 500 parts of nutgrass galingale rhizome, 50 to 500 parts of motherwort herb, 30 to 250 parts of achyranthes, 50 to 400 parts of white paeony root, and 50 to 400 parts of rhizoma corydalis. The Chinese angelica has the effects of nourishing the blood and promoting blood circulation; the red paeony root and the tree peony bark have the effects of cooling blood and removing blood stasis; the radix bupleuri and the nutgrass galingale rhizome have the effects of soothing the liver and regulating qi; the motherwort herb removes the blood stasis and regulates menstruation; the peach seed breaks blood and induces menstruation; the peony relaxes spasm and relieves pain; and the achyranthes has the effect of guiding stasis down. By matching all the medicaments in the invention, the medicament has the effects of soothing the liver and regulating qi and removing blood stasis and regulating the menstruation, and has obvious curative effect on a uterine myoma patient caused by qi stagnation and blood stasis.

A myoma screw, for firmly fixing a uterine myoma of a patient to extract the uterine myoma easily during a laparoscopic myomectomy, wherein the apparatus is introduced into an abdominal cavity of the patient through a cannula, includes: a body part having a cross-sectional diameter smaller than that of the cannula; a fixing part, having a shape of a circular cone, for fixing the uterine myoma firmly; and a gripping part for applying traction force to the fixing part fixed into the uterine myoma. By using the apparatus during the laparoscopic myomectomy, the uterine myoma can be extracted safely, while obtaining a sufficient view of an operative field in a restricted space created by the cannula.

The invention relates to a medicine, in particular to a medicine for treating female genitourinary system inflammation. The medicine is prepared by the following raw medicine materials in parts by weight: 25-35 parts of felwort, 8-12 parts of rhizoma alismatis, 8-12 parts of cortex dictamni, 8-12 parts of coptis, 25-32 parts of lightyellow sophora root, 7-13 parts of akebiaquinata, 8-12 parts of Cyrtomium fortunei, 7-14 parts of fineleaf schizonepeta herb, 12-20 parts of Chinese thorowax root, 12-18 parts of plantain seed, 12-18 parts of golden cypress, 7-12 parts of stiff silkworm, 9-12 parts of pangolin scale, 12-18 parts of Salvia miltiorrhiza Bunge, 8-15 parts of licorice root, 12-20 parts of Chinese angelica, 12-20 parts of divaricate saposhnikovia root and 8-15 parts of fructus cnidii. The invention has the advantages that the effects of the medicine on female genitourinary system inflammation, including acute and chronic vaginitis, pruritus vulvae, leucorrhea increase, peculiar smell, cervicitis, cervical erosion, pelvic inflammation, ovarian cyst and the like according to a great amount of clinical experiments are obvious, and certain efficacies on mammary gland proliferation, hysteroptosis, uterine myoma, endometriosis and the rehabilitation therapy after delivery operation are also obtained.

The present invention relates to Chinese medicine and is especially one kind of Chinese medicine for treating women's ovarial tumor and uterine myoma. The Chinese medicine is prepared with 21 kinds of Chinese medicinal materials including saffron, burreed rhizome, ground bettle, nutagrass flatsedge rhizome, bitter orange, etc. The medicine is used in treating women's uterine myoma, overal tumor, ovarial cyst and other diseases; and has high curative effect.

The invention belongs to the technical field of medicine and relates to a 1,4-dihydrobithiophene [3', 2': 5, 6] bithiapyran [4, 3-c] pyrazol-3-carboxylic acid derivative and application thereof used as an estrogen receptor, in particular to a 1,4-dihydrobithiophene [3', 2': 5, 6] bithiapyran [4, 3-c] pyrazol-3-carboxylic acid derivative and a pharmaceutically acceptable salt, or a stereoisomer thereof and a prodrug as well as a pharmaceutically acceptable vector in compatibility or a diluent used as an estrogen receptor. The structural general formula of the derivative is disclosed in the specification, and in the structural formula, n R1 can be independently selected from a substituted or unsubstituted amido group, and R2 can be independently selected from H or an acetyl group. The derivative can be used for treating and preventing various diseases related to estrogen functions, such as diseases related to estrogen deficiency, estrogen sensitive cancer and hyperplasia, endometriosis, uterus myoma and osteoarthritis. Compounds or compositions of the derivative can also be independently used or combined with progestogen or a hormoneantagonist as a contraceptive.

The invention discloses a traditional Chinese medicine for treating uterine myoma and a preparation method thereof. The traditional Chinese medicine consists of the following raw materials in parts by weight: 40-50 parts of codonopsis pilosula, 30-40 parts of prepared rehmannia roots, 15-30 parts of dried tangerine or orange peel, 30-45 parts of poria cocos, 40-50 parts of radix angelicae sinensis, 40-50 parts of rhizoma cyperi, 100-120 parts of dandelion, 30-40 parts of white paeony root, 20-30 parts of perilla stem, 150-200 parts of purslane, 30-40 parts of ligusticum wallichii, 100-120 parts of safflower, 50-60 parts of cortex lycii radicis and 20-25 parts of liquorice. The preparation method comprises the following steps: preparing codonopsis pilosula, prepared rehmannia roots, dried tangerine or orange peel, poria cocos, radix angelicae sinensis, rhizoma cyperi, dandelion, white paeony root, perilla stem, purslane, ligusticum wallichii, safflower, cortex lycii radicis, liquorice and honey in parts by weight; firstly decocting purslane and dandelion for 24 hours to obtain decoction, filtering, discarding decoction dregs, further decocting into extract, adding safflower, uniformly mixing, drying, crushing into 120-mesh fine powder; drying the rest of medicinal raw materials, crushing into 120-130-mesh fine powder, carrying out ultraviolet irradiation sterilization; and the traditional Chinese medicine has pharmacologic actions of clearing away heat and toxic materials, diminishing inflammation, relieving pains, promoting blood circulation to remove blood stasis and resolving hard lump.

The invention discloses a medicine for treating uterine myoma and a preparation method of the medicinethereof. The medicine is obtained by combining the honey with 30 traditional Chinese medicines in total, such as unprocessed radix aconiti lateralis, unprocessed rhizoma pinelliae, herba asari, ramulus cinnamomi, poria, rhizoma zingiberis recens, rhizoma zingiberis, cortex cinnamomi, rhizoma atractylodis, radix astragali, herba ephedra, cornus officinalis and radix bupleuri; and the medicinal materials are jointly utilized with the honey after the meidicinal materials are ground or decocted with water to extract a thick paste, thereby preparing being prepared into the traditional Chinese medicine preparation, including capsules or tablets, etc. The traditional Chinese medicine for treating uterine myoma provided by the invention is capable of dissolving stasis and dissipating haematoma, activating blood without the hurt of body resistance, and strengthening body resistance without stasis; after the traditional Chinese medicine is applied, the uterine myoma is controlled in different degrees, the uterine myoma is reduced, and the symptoms including irregular menstruation, lumboabdominal pain, intimitis with ovarian cyst and the like are obviously improved; and in addition, the medicine is free from obvious toxic and side effects and liable to be accepted by the patients.

A uterine leiomyoma cutting device comprises a plastic bag and a cutting knife, wherein that plastic bag is use for placing uterine leiomyoma therein, and the cutting knife is used for cutting uterineleiomyoma in the plastic bag. Four broaching ropes are arranged around the plastic bag, and a broaching ring is arranged at the end of the broaching rope. The cutting tool comprises a semicircular handle connected with a semicircular groove at one end of the semicircular handle, and a cutting tool is arranged on the semicircular groove. The invention provides a uterine myoma cutting device, whichavoids the use of a uterine myoma electric rotary cutter from the source, avoids the malignant component splashing into the pelvis and abdominal cavity when the uterine myoma sarcoma changes, and improves the safety of the laparoscopic uterine myoma operation.

The invention relates to the field of traditional Chinese medicine gynecology, in particular to externally applied traditional Chinese medicine honeyed pills for treating uterine cold, dysmenorrhea and hysteromyoma. The externally applied traditional Chinese medicine honeyed pills for treating uterine cold, dysmenorrhea and hysteromyoma are prepared from traditional Chinese medicinal raw materialsas follows: radix angelicae sinensis, flos carthami, radix astragalis, radix sophorae flavescentis, borneol, radix glycyrrhizae, semen arecae, rhizoma ligustici, semen persicae, herba leonuri, rhizoma atractylodis macrocephalae, radix rehmanniae praeparata, caulis spatholobi, frankincense and resina draconis. The traditional Chinese medicinal raw materials are ground into fine powder, the fine powder is evenly mixed with rock candy, honeyed pills are prepared by refined honey, the honeyed pills are pasted in a navel by an adhesive tape, and a moxibustion instrument is used cooperatively for moxibustion for 30 minutes. The externally applied traditional Chinese medicine honeyed pills for treating uterine cold, dysmenorrhea and hysteromyoma are external used medicines, have no side effect on the body, are simple and convenient to use, avoid uncomfortable feeling of oral medicines and do not affect normal life; clinical tests verify that the effect is remarkable, the medicinal property is mild, toxic and side effects are avoided, the effective rate is 100 % and the cure rate is 90%.

The invention provides a hysteromyoma three-dimensional model reconstruction method, which comprises the following steps of: defining a region: segmenting a region with a specific voxel value range according to a voxel value of a nuclear magnetic image, and recording the region as a myoma region; wherein points of the myoma area are selected, and the interference area outside the myoma area is removed through area growth; A myoma region correction step: utilizing erasure filling or range limitation to correct the myoma region; An image conversion step: extracting a nuclear magnetic image of the myoma region, recording the nuclear magnetic image as an extracted nuclear magnetic image, and binarizing the extracted nuclear magnetic image to obtain a converted image; and a three-dimensional reproduction step: carrying out surface reconstruction on the converted image to obtain a myoma three-dimensional model of grid data composed of triangular surfaces. A three-dimensional model of hysteromyoma is quickly reconstructed, and the problems of auxiliary positioning and monitoring are solved by combining high-strength ultrasonic treatment equipment; A three-dimensional model of a uterine myoma focus is constructed through a nuclear magnetic image of a patient, and the size, the shape and the direction of myoma can be clearly displayed.

The invention discloses traditional Chinese medicine for treating uterine myoma. The traditional Chinese medicine is prepared from the following crude drugs in parts by weight: 5 to 15 parts of radix astragali seu hedysari, 5 to 15 parts of radix codonopsis, 6 to 12 parts of rhizoma sparganii, 6 to 12 parts of rhizoma curcumae, 6 to 12 parts of semen vaccariae, 5 to 15 parts of squama manitis, 10 to 20 parts of Chinese angelica, 10 to 20 parts of fructus ligustri lucidi, 5 to 15 parts of radix achyranthis bidentatae, 5 to 15 parts of radix rehmanniae preparata, 5 to 15 parts of rhizoma atractylodis macrocephalae, 5 to 15 parts of rhizoma anemarrhenae, 10 to 20 parts of radix rehmanniae and 10 to 20 parts of radix paeoniae alba. The traditional Chinese medicine disclosed by the invention has a good treatment effect on uterine myoma; no expensive crude drugs are used so that the traditional Chinese medicine is low in cost and the materials are easy to take; the traditional Chinese medicine has no toxic or side effect and has the advantages of rapid effect, short treatment course and high curing rate.

The invention discloses an externally applied traditional Chinese medicine composition for gynecological diseases and a use method thereof, and belongs to the technical field of treatment or alleviation of gynecological diseases. The externally applied traditional Chinese medicine composition for gynecological diseases comprises 4 to 6 parts of rhizoma sparganii, 4 to 8 parts of rhizoma curcumae,5 to 9 parts of herba menthae, 4 to 7 parts of notopterygium roots, 4 to 8 parts of radix angelicae pubescentis and 5 to 7 parts of pig's toenail, is used for treating symptoms caused by stagnation and cold-dampness, and has the treatment effects on irregular menstruation, dysmenorrhea, pelvic effusion, pelvic inflammation and infertility caused by blood deficiency, blood stasis and stagnation ofliver-qi; and the treatment time is short, trauma cannot be left, and certain conditioning and relieving effects are achieved on ovarian cyst and hysteromyoma. The rhizoma sparganii and the rhizoma curcumae are used as monarch medicine to achieve the effects of dissolving stasis, breaking blood and relieving pain; the notopterygium roots is used as minister medicine; the radix angelicae pubescentis is used for eliminating dampness, dispelling cold and relieving pain; the herba menthae is used as assistant medicine to achieve the effects of dispersing stagnated liver qi to relieve depression and clearing away medication heat; and the pig's toenail is used as guide medicine to achieve the effects of detoxication, tissue regeneration promotion and anti-inflammation.

The invention discloses a Chinese medicinal preparation for treating infertility, which is mainly prepared from the following raw materials in part by weight: 6 to 10 parts of pangolin scales, 6 to 10 parts of safflower, 6 to 10 parts of Mongolian dandelion herb, 6 to 10 parts of hiraute shiny bugleweed herb, 6 to 10 parts of weeping forsythia capsule, 6 to 10 parts of red peony root, 6 to 10 parts of nutgrass galingale rhizome and 6 to 10 parts of combined spicebush root. The raw materials of the Chinese medicinal preparation provided by the invention have the effects of invigorating the circulation of blood and / or removing blood stasis. The Chinese medicinal preparation has quick response and obvious effect on the infertility, has very good treatment effect on gynopathy, such as blockage of the fallopian tubes, appendagitis, cervical erosion, unusual leucorrhoea, pelvic inflammatory disease, uterine myoma and vaginitis and the like and can also be applied to daily life care of vast women.

A sodium alginate microsphere containing gynecologic medicine used as vascular plocking agent for treating hysteromyoma, endometrioma, etc is prepared through preparing the solution of gynecologic medicine, the solution of sodium alginate and the solution of barium (or magnesium) chloride, and sequentially mixing.

The invention provides a Gynecopathy treating medicine and its preparing method, wherein the medicine is prepared from Cineses medicinal herbs including notoginseng, cyperus tuber, star aniseed, dried wood-louse, black ant, herb of Chinese fevervine, buckwheat, root of hairy clovershrub, Bupleurum root.

The invention discloses a traditional Chinese medicine composition for treating blood stasis type uterine myoma. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine materials: raw hawthorn, endothelium corneum gigeriae galli, touguxiao, Chinese ixora flower, borneol, sarcandra, preserved black bean with ginger, ligusticum wallichii, levant cotton root, honey-fried licorice root and beautiful millettia root. The traditional Chinese medicine composition disclosed by the invention has the advantages of being remarkable in treating blood stasis type uterine myoma, quick to become effective, high in cure rate, and has an effective rate of 100% and a cure rate of 98%.

The invention belongs to the technical field of biological products and discloses a health food for improving female fertility. The health food is prepared from haematococcus pluvialis, wood frog spawn peptide powder, collagen peptide powder, white granulated sugar powder, isomalto-oligosaccharide powder and saussurea involucrate culture. The health food is conducive to recovery of female fertility and prevention and treatment of uterine myoma and further has an anti-aging function.

The invention provides a medicine for interventional treatment of uterine myoma. The medicine belongs to a polyoxyethylene lauryl alcohol ether compound, called lauromacrogol for short; after lauromacrogol is injected under the envelope of an uterine myoma body, a layer of fibre textures is formed in the lower layer of the envelope; blood vessels are injured and permanently occluded by the fibre textures, so that the uterine myoma body is reduced and gradually disappears; uterine myoma is subjected to interventional treatment by utilizing the medicine, so that the functions of an uterus can be intactly retained; in addition, fertilization is not influenced; operative wound and a series of post-operative complications are avoided; the effect of the medicine disclosed by the invention is comparable with operation in the aspect of symptom improvement; by means of interventional treatment of uterine myoma by utilizing the medicine, the medicine disclosed by the invention is small in wound, rapid in recovery, free from being in hospital and easy for patients to accept; compared with the traditional operative treatment, interventional treatment of uterine myoma by utilizing the medicine is simple and convenient; furthermore, blood transfusion is generally unnecessary; the medicine disclosed by the invention has the advantages of being minimally invasive, repeatable, accurate for locating, high in curative effect, rapid in effect, few in complications and the like and brings a good development prospect for clinical treatment of uterine myoma.

The invention belongs to the technical field of medicines and particularly relates to a medicine combination for treating uterine myoma. The medicine combination consists of components such as kelp, suberect spatholobus stem, inner membrane of chicken gizzard, Sichuan lovage rhizome, red-rooted salvia root, edible tulip, pinellia tuber, cattail pollen, atractylodes rhizome and coix seed. The medicine combination provided by the invention has a definite treatment effect for treating the uterine myoma, is high in safety and can be used as a preferred medicine for treating the uterine myoma.

The invention discloses a traditional Chinese medicine for treating liver qi stagnation type uterine myoma. The traditional Chinese medicine is prepared from snake butter, fruit of tibet lancea, achyranthes aspera, peach kernels, fleshfingered citron flowers, lathyrus davidii, herba lycopi, pinellia ternate, plum blossom and livistona chinensis seeds. The traditional Chinese medicine can be used for treating liver qi stagnation type uterine myoma clinically.

The present invention relates to Chinese medicine and is especially one kind of Chinese medicine for treating women's ovarial tumor and uterine myoma. The Chinese medicine is prepared with 21 kinds of Chinese medicinal materials including saffron, burreed rhizome, ground bettle, nutagrass flatsedge rhizome, bitter orange, etc. The medicine is used in treating women's uterine myoma, overal tumor, ovarial cyst and other diseases; and has high curative effect.

The invention relates to a stripping device, in particular to a stripping device of the myoma of uterus for the gynecology department. The invention provides the stripping device of the myoma of uterus for the gynecology department, and the stripping device can carry out automatic stripping, can be easily and conveniently used and has small harm to patients. The tripping device of the myoma of uterus for the gynecology department comprises a stripper, a first collecting frame, a discharging mechanism, a cutting mechanism, a cutting component and a feeding mechanism, wherein the first collecting frame is arranged on the stripper; the discharging mechanism is arranged between the stripper and the first collecting frame; the cutting mechanism is arranged on the stripper; the cutting component is arranged on the cutting mechanism; and the feeding mechanism is arranged on the first collecting frame. The telescopic rod of an electric push rod is controlled by a control module to be static for one minute, a gynecologist can screw down a collecting pipe, then, the gynecologist can take out the myoma on the collecting pipe, and a discharging effect is achieved.

The invention is suitable for the technical field of medical image processing, and particularly relates to a hysteromyoma target image acquisition method based on a residual network structure, which comprises two stages of model training and model application. The model training comprises the following steps: S1, on an original sample ultrasonic image, carrying out lesion target image region labeling on a region containing a hysteromyoma image in a rectangular frame form; s2, the standard annotation image is detected through an improved YOLOv3 target detection model; and S3, results are unified, and a trained improved YOLOv3 target detection model is obtained. During application, a to-be-detected ultrasonic image is input into the trained improved YOLOv3 target detection model for detection, and a hysteromyoma target image area result is obtained. According to the method, the acquisition precision of the hysteromyoma image area can be improved, the detection speed is high, and the adaptability to small-target and multi-target tasks is high.

The invention discloses an ultrasonic image segmentation method for a dynamics-based statistical shape model. The method comprises the following steps: 1. manually defining the central point of an ultrasonic image target region; 2. establishing a dynamics-based statistical shape model of the profile of target region profile for serving as a prior model of the target region; 3. calculating a radial characteristic profile model of each radius for serving as a likelihood probability model of the target region; 4. converting the segmentation process of the target region into the calculation of the maximum posterior probability of the entire profile according to the statistical shape model and the radial characteristic profile model; 5. updating the length of the radius of each angle to form a new profile curve; 6. calculating the maximum posterior probability of the new profile curve, and returning to the step 5 when the value of the maximum posterior probability is smaller than a set threshold; 7. converging to obtain a new profile serving as the profile region for the segmentation of the target region. By adopting the method, the target region of uterine myoma in a two-dimensional ultrasonic image can be segmented accurately by means of simple manual interaction.